{
  "image_filename": "table_p6_det_5_006.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/table_p6_det_5_006.png",
  "image_type": "Table",
  "page_number": 6,
  "block_id": "det_5_006",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "A table listing various influenza vaccine types (Egg-based IIV4s, cell culture\u2013based ccIIV4, recombinant RIV4, and live attenuated LAIV4) alongside their contraindications and precautions. does not support the claim because the table only provides contraindications and precautions for different vaccine types and does not mention any pivotal trial comparison between Flublok (quadrivalent) and Fluarix (quadrivalent) or present any head-to-head evaluation data.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table listing various influenza vaccine types (Egg-based IIV4s, cell culture\u2013based ccIIV4, recombinant RIV4, and live attenuated LAIV4) alongside their contraindications and precautions.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table only provides contraindications and precautions for different vaccine types and does not mention any pivotal trial comparison between Flublok (quadrivalent) and Fluarix (quadrivalent) or present any head-to-head evaluation data.",
    "confidence_notes": null
  }
}